Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating activities
Net income	$ 38,468	$ 76,640	$ 188,822	$ 215,436
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	79,370	74,600	236,527	216,606
Impairments	19,258	1,571	36,052	11,096
Amortization of deferred financing costs	2,325	1,475	5,944	3,637
Amortization of debt discounts, net	330	318	982	947
Amortization of deferred losses on interest rate swaps	702	702	2,106	2,106
Stock-based compensation expense			15,106	12,805
Loss on debt extinguishment			0	172
Gain on dispositions of real estate and other assets	(3,661)	(23,302)	(66,450)	(63,107)
Non-cash revenue			(26,894)	(30,165)
Other			32	10
Changes in operating assets and liabilities:
Deferred costs and other assets, net			3,798	(1,683)
Accounts payable, accrued expenses and other liabilities			(22,477)	(28,975)
Net cash provided by operating activities			373,548	338,885
Investing activities
Acquisitions of real estate			(419,765)	(1,118,290)
Capitalized real estate expenditures			(65,649)	(55,318)
Investments in loans receivable			(13,672)	(12,700)
Proceeds from dispositions of real estate and other assets			249,028	183,767
Net cash used in investing activities			(250,058)	(1,002,541)
Financing activities
Borrowings under revolving credit facilities			424,000	1,267,800
Repayments under revolving credit facilities			(479,500)	(1,556,200)
Repayments under mortgages payable			(413)	(391)
Borrowings under term loans			300,000	800,000
Deferred financing costs			(269)	(17,028)
Proceeds from issuance of common stock, net of offering costs				531,565
Repurchase of shares of common stock, including tax withholdings related to net stock settlements			(1,457)	(6,427)
Common stock dividends paid			(281,020)	(255,870)
Preferred stock dividends paid			(7,763)	(7,763)
Net cash (used) provided by financing activities			(46,422)	755,686
Net increase in cash, cash equivalents and restricted cash			77,068	92,030
Cash, cash equivalents and restricted cash, beginning of period			61,953	17,799
Cash, cash equivalents and restricted cash, end of period	139,021	109,829	139,021	109,829
Cash paid for interest, net of interest capitalized			133,071	99,575
Interest capitalized			1,005	741
Cash paid for income taxes			919	676
Supplemental Disclosures of Non-Cash Activities:
Dividends declared and unpaid	$ 94,635	$ 92,595	94,635	92,595
Accrued capitalized costs			39,552	18,103
Accrued market-based award dividend rights			2,429	998
Derivative changes in fair value			19,104	$ 39,502
Financing provided in connection with disposition of assets			33,000
Right-of-use assets			22,635
Right-of-use liabilities			$ 22,635